Cargando…

Imaging tumour thrombus of clear cell renal cell carcinoma: FDG PET or PSMA PET? Direct in vivo comparison of two technologies

Detalles Bibliográficos
Autores principales:	Saadat, Seyedehpariya, Tie, Bibiana, Wood, Simon, Vela, Ian, Rhee, Handoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635239/ https://www.ncbi.nlm.nih.gov/pubmed/29034176 http://dx.doi.org/10.1016/j.eucr.2017.09.010

Ejemplares similares

Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
por: Rhee, Handoo, et al.
Publicado: (2016)

FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer
por: Kichloo, Asim, et al.
Publicado: (2020)

Meta-analysis of (18) F-PSMA-1007 PET/CT, (18) F-FDG PET/CT, and (68)Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
por: Yu, Wenxiao, et al.
Publicado: (2023)

Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
por: Boellaard, Ronald, et al.
Publicado: (2010)

(68)Ga-PSMA PET/CT Versus (18)F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Diagnostic value of (18)F-FDG PET/CT versus contrast-enhanced MRI for venous tumour thrombus and venous bland thrombus in renal cell carcinoma
por: Zhu, An-hui, et al.
Publicado: (2022)

Prognostic implications of dual tracer PET/CT: PSMA ligand and [(18)F]FDG PET/CT in patients undergoing [(177)Lu]PSMA radioligand therapy
por: Michalski, Kerstin, et al.
Publicado: (2020)

The Use of MRI and PET Imaging Studies for Prostate Cancer Management: Brief Update, Clinical Recommendations, and Technological Limitations
por: Mansbridge, Margaret, et al.
Publicado: (2019)

PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings
por: Gühne, Falk, et al.
Publicado: (2021)

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
por: Boellaard, Ronald, et al.
Publicado: (2009)

Tumor Thrombus within the Superior Sagittal Sinus Detected on FDG PET Venography
por: Chandra, Piyush, et al.
Publicado: (2023)

The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

The effect of Q.Clear reconstruction on quantification and spatial resolution of 18F-FDG PET in simultaneous PET/MR
por: Tian, Defeng, et al.
Publicado: (2022)

Comparative Findings Between (68)Ga-PSMA and (18)F-FDG PET/CT for Hepatocellular Carcinoma
por: Erhamamcı, Seval, et al.
Publicado: (2020)

Isolated, PSMA-negative penile metastasis from castration resistant prostate adenocarcinoma, identified by FDG-PET
por: Chau, Matthew, et al.
Publicado: (2022)

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Adrenocortical Carcinoma with Inferior Vena Cava Thrombus on (18)F-FDG-PET-Computed Tomography
por: Tripathy, Sarthak, et al.
Publicado: (2020)

Prognostic Values of TIGAR Expression and (18)F-FDG PET/CT in Clear Cell Renal Cell Carcinoma
por: Wang, Xiaoyan, et al.
Publicado: (2020)

Expanding the role of PSMA PET in active surveillance
por: Jain, Anika, et al.
Publicado: (2023)

PSMA-PET in the early stages of prostate cancer
por: Barbosa, Felipe de Galiza
Publicado: (2023)

Solitary castrate-resistant prostate cancer metastasis to adrenal gland with concordant intense avidity on PSMA and FDG PET
por: McGeorge, Stephen, et al.
Publicado: (2021)

All that Glitters on PSMA is Not a Lesion: An Unusual Artifact on PSMA PET/CT
por: Dev, Indraja D., et al.
Publicado: (2021)

PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature
por: Muselaers, Stijn, et al.
Publicado: (2022)

The utility of (18)F-FDG PET/CT in brain tumours diagnosis
por: Pietrzak, Agata, et al.
Publicado: (2022)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
por: Bertagna, Francesco, et al.
Publicado: (2020)

Extensive tumor thrombus in a case of carcinoma lung detected by F18-FDG-PET/CT
por: Mudalsha, Ravina, et al.
Publicado: (2011)

PSMA Expression in Multinodular Thyroid Neoplasm on Simultaneous Ga-68-PSMA PET/MRI
por: Jena, Amarnath, et al.
Publicado: (2017)

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
por: Ceci, Francesco, et al.
Publicado: (2021)

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
por: Leung, Kevin H., et al.
Publicado: (2022)

Evaluation of SUVlean consistency in FDG and PSMA PET/MR with Dixon-, James-, and Janma-based lean body mass correction
por: Zhao, Jun, et al.
Publicado: (2021)

Clinical perspectives of PSMA PET/MRI for prostate cancer
por: Barbosa, Felipe de Galiza, et al.
Publicado: (2018)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
por: Combes, Alexander D., et al.
Publicado: (2022)

Musculoskeletal pitfalls in (68)Ga-PSMA PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)

PSMA PET imaging in the diagnosis and management of prostate cancer
por: Houshmand, Sina, et al.
Publicado: (2023)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dt108c8tuk5pfmvtt39vga5o4i